A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexMale
Age18-90
SponsorAntelope Surgical Solutions, Inc
About this trial
A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS
Eligibility criteria
Qualifiers
suspected prostate cancer warranting standard of care multi-core prostate biopsy
Disqualifiers
Patients receiving same-day therapeutic Lutetium-177 or Actinium-225 PSMA receptor radiation isotope therapy treatment
Patients with pre-existing, impaired or abnormal hepatic function, renal function, cardiac function, and abnormal elevated temperature
Patients with a creatinine clearance cutoff (CrCl) of < 60 mL/min
Trial design
Treatments tested in this trial
- AS1986NS
Treatment groups
10 Participants
are divided into 1 treatment groupLocations
3Taiwan
Linkou Chang Gung Memorial Hospital333, Taoyuan CityTaiwan, Taiwan
United States
HCA Florida Kendall Hospital33175, MiamiFlorida, United States
Icahn School of Medicine at Mount Sinai (ISMMS)10029, New YorkNew York, United States
Sponsors and collaborators
Antelope Surgical Solutions, Inc
Lead sponsor
Source ClinicalTrials.gov